Dupilumab remarkably improved eustachian tube obstruction: a case of mepolizumab-resistant eosinophilic otitis media
Takeshita Y1, Tada Y1, Okano M2, To M3, To Y4
1Department of Pulmonary Medicine, International University of Health and Welfare Narita Hospital, Chiba, Japan.
2Department of Otorhinolaryngology, International University of Health and Welfare, Chiba, Japan.
3Department of Laboratory Medicine, Dokkyo Medical University, Saitama Medical Center, Koshigaya City, Saitama, Japan.
4Department of Pulmonary Medicine, International University of Health and Welfare Atami Hospital, Shizuoka, Japan.
J Investig Allergol Clin Immunol 2023; Vol. 33(1)
Key words: Dupilumab, Eosinophil Otitis Media, Periostin